Coronary Artery Bypass Graft Surgery
30
1
1
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
2 terminated out of 30 trials
90.0%
+3.5% vs benchmark
27%
8 trials in Phase 3/4
17%
3 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (30)
Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery
Cardiac Rehabilitation in Coronary Artery Bypass Graft Surgery
Development of an Arterial Pressure Monitoring Set Fixation Apparatus
Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures
Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery
The Effect of Listening to Holy Quran Recital on the Incidence of Delirium Post-CABG
Discharge Planning Program for Post CABG Patients
Inspiratory Muscle Training Prior to Conventional and Minimal Invasive Heart Surgery
Effect of Using Walking Aid on Mobility
Power Lung Versus Acapella After Coronary Artery Bypass Graft Surgery
The Effect of Lavender Oil Inhalation on Pain, Anxiety and Sleep Quality After Coronary Artery Bypass Graft
Transitional Rehabilitation in CABG Patients
The Effect of Reflexology After Coronary Artery Bypass Graft Surgery
Vitamin C in Cardiac Surgery Patients
Effects of ACBT on Pulmonary Function After CABG During Phase 1 Cardiac Rehabilitation
Desflurane,Brain Natriuretic Peptide and Cardiac Surgery
Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery
A(f)MAZE-CABG Study
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion
Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery